Sign in

NCT06579807Recruiting

Cardiac Rehabilitation and Coronary Artery Disease

Effect of a Cardiovascular Rehabilitation Program on Atherosclerosis, Endothelial Function and Inflammation in Patients With Coronary Artery Disease

Source: ClinicalTrials.gov · Last updated 27 Mar 2026

Brief summary (registry, in English)

Patients with coronary artery disease (CAD) aged 40-70 years will undergo exercise training (thrice weekly for 12 weeks). A reference group composed of healthy individuals will be included. Evaluations will be conducted at baseline and after the intervention period during two visits. During the first visit, carotid artery thickness will be assessed via ultrasound before and after a cardiopulmonary exercise testing. The second visit will include the evaluation of endothelial function using venous occlusion plethysmography. After this, participants will engage in 30 minutes of moderate-intensity aerobic exercise, and blood samples will be collected pre- and post-exercise. Circulating levels of kynurenine pathway (KP) metabolites (Tryptophan, kynurenine, kynurenic acid, and quinolinic acid), pro-inflammatory cytokines, cell adhesion molecules, and lipid profiles will be measured via Enzyme-Linked Immunosorbent Assay (ELISA), multiplex essays, and biochemical analysis; respectively.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
27 Aug 2024
Start date
1 Oct 2024
Primary completion date
31 Dec 2026
Lead sponsor
Instituto Nacional de Cardiologia de Laranjeiras
NCT number
NCT06579807

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 1 Oct 2024 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • diagnosis of heart failure, pulmonary disease, Chagas disease, or tuberculosis

Other

  • regular physical exercise practice (≥ 3 days/week for 30 min) over the past 6 months
  • malnutrition (body mass index \[BMI\] \< 18.5 kg/m²)
  • smoking
  • obesity (BMI ≥ 30 kg/m²)

Who the study is looking for

  • Eligible CAD patients will be those aged 40 to 70 years, of both sexes, entering the cardiac rehabilitation program at HUPE. CAD will be defined as any acute coronary syndrome, including myocardial infarction with and without ST-segment elevation, and unstable angina (all defined by characteristic histories, electrocardiographic abnormalities, and cardiac enzyme abnormalities), or obstructive CAD diagnosed via coronary angiography (defined as ≥ 50% stenosis of any epicardial coronary artery) in patients with stable angina.
  • Healthy controls: adults aged 40 to 70 years, of both sexes, without CAD evidence.

Age in the registry: 40 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Rio de Janeiro State University
Coordinator of this site? Confirm its status
Rio de JaneiroBrazilRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.